Genaissance Licenses Haplotype Database to Pfizer | GenomeWeb

NEW YORK, Oct. 9 - Genaissance Pharmaceuticals has licensed certain data from its haplotype library to drug giant Pfizer, Genaissance said on Tuesday.

Financial terms of the deal were not disclosed.

Genaissance, based in New Haven, Conn., has already identified roughly 80,000 haplotypes from almost 5,000 genes and says it intends to discover haplotypes across the entire genome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.